BRANDL TALOS advises Aitiologic on EUR 6.4 million seed financing round

Press release • Corporate Law & Transactions from Roman Rericha, Stephan Strass, Markus Reinfeld, Alyssa Nimmervoll

BRANDL TALOS advises Aitiologic on EUR 6.4 million seed financing round

BRANDL TALOS has advised Vienna-based precision medicine company aitiologic on its EUR 6.4 million seed financing round. The significantly oversubscribed financing was co-led by Heal Capital and Ananda Impact Ventures. Existing investors PUSH and LANA Ventures continued their support, alongside experienced biotech founders. Dr. Gordon Sanghera CBE FRS, co-founder and former CEO of Oxford Nanopore Technologies, also participated in the round as an investor and joined aitiologic’s advisory board.

aitiologic develops tissue-resolved liquid biopsy solutions based on its proprietary aitios® platform, which combines genomic, epigenomic and fragmentomic information from circulating cell-free DNA with AI-powered interpretation. The company’s lead program focuses on identifying the risk of preeclampsia from a routine first-trimester blood sample, with broader potential applications in precision medicine, patient stratification and disease monitoring.

The new funding will support the further development and large-scale clinical validation of the aitios® platform, including aitiologic’s ongoing preeclampsia validation study with the Fetal Medicine Foundation, as well as regulated product development.

The BRANDL TALOS deal team advising aitiologic on this deal consisted of Stephan Strass, Roman Rericha, Markus Reinfeld and Alyssa Nimmervoll.

Heal Capital was advised by CMS Reich-Rohrwig Hainz (Georg Gutfleisch), Ananda Impact Ventures was advised by POELLATH (Philipp von Braunschweig).

The team

Roman Rericha

Array
(
    [0] => WP_Term Object
        (
            [term_id] => 5
            [name] => Attorney at Law
            [slug] => attorney-at-law
            [term_group] => 0
            [term_taxonomy_id] => 5
            [taxonomy] => category
            [description] => 
            [parent] => 0
            [count] => 15
            [filter] => raw
        )

    [1] => WP_Term Object
        (
            [term_id] => 4
            [name] => Partner
            [slug] => partner
            [term_group] => 0
            [term_taxonomy_id] => 4
            [taxonomy] => category
            [description] => Partner
            [parent] => 0
            [count] => 11
            [filter] => raw
        )

)

Partner / Gesellschaftsrecht & Transaktionen, Venture Capital & Start-ups, Fund Formation

Roman advises on complex cross-border M&A and private equity transactions. He also regularly supports foreign and Austrian venture capital funds with investments in Austria as well as start-ups in large-scale financing rounds.

University of Vienna, Faculty of Law (Mag. iur. 2005),
Faculty of Business, Economics and Statistics, (Mag. rer.soc.oec. 2007)

Stephan Strass

Array
(
    [0] => WP_Term Object
        (
            [term_id] => 5
            [name] => Attorney at Law
            [slug] => attorney-at-law
            [term_group] => 0
            [term_taxonomy_id] => 5
            [taxonomy] => category
            [description] => 
            [parent] => 0
            [count] => 15
            [filter] => raw
        )

    [1] => WP_Term Object
        (
            [term_id] => 4
            [name] => Partner
            [slug] => partner
            [term_group] => 0
            [term_taxonomy_id] => 4
            [taxonomy] => category
            [description] => Partner
            [parent] => 0
            [count] => 11
            [filter] => raw
        )

)

Partner / Gesellschaftsrecht & Transaktionen, Venture Capital & Start-ups, BioTech & Lifescience

Stephan advises innovative start-ups, institutional and strategic investors and other companies on acquisitions, financing rounds, joint ventures and exit transactions with a focus on highly regulated industries such as life sciences, biotech and leisure & entertainment. He further specializes in commercial transactions in the life science and biotech sector, including university spin-offs, strategic collaborations, patent and technology license agreements and IP purchase transactions.

He has co-authored commentaries on the EU Merger Act and the Investment Fund Act, and is the author of many academic publications.

University of Vienna, Faculty of Law (Mag. iur. 2015)
Harvard Law School, Master of Laws (LL.M. 2019)

Markus Reinfeld

/ Corporate Law & Transactions, Venture Capital & Start Ups, Real Estate Law

Markus has many years of experience in the transactional field, with a focus on start-ups, venture capital, private equity, and other M&A transactions. In addition to his legal practice, Markus is the co-founder of a legal tech tool as well as a fintech company in the social business sector.

He is the author and co-editor of the Sample Collection of IT Contracts and the author of several other academic publications.

Santa Clara University, Master of Laws (LL.M. 2014)
University of Vienna,, Master of Laws (LL.M. 2013)
University of Vienna, Faculty of Law (Mag, iur 2011)
University of Vienna,, Political Science (BA)

Alyssa Nimmervoll

Array
(
    [0] => WP_Term Object
        (
            [term_id] => 21
            [name] => Associate
            [slug] => associate
            [term_group] => 0
            [term_taxonomy_id] => 21
            [taxonomy] => category
            [description] => 
            [parent] => 0
            [count] => 27
            [filter] => raw
        )

)

Associate / Corporate Law & Transactions

Alyssa is part of our team since 2026.

WU Vienna University of Economics and Business (LL.M. 2025)

Latest insights into
Corporate Law & Transactions

BRANDL TALOS advises Sportradar on $170 million sale of Synergy Sports to Teamworks Innovations

Press release • Corporate Law & Transactions from Roman Rericha, Stephan Strass, Markus Reinfeld, Nina Atanasovska, Daniel Habich

BRANDL TALOS has advised its longstanding client Sportradar on the $170 million sale of Atrium Sports, the coaching and scouting business of Synergy Sports, to Teamworks Innovations.

BRANDL TALOS advises Graph Therapeutics on additional USD 5 million financing

Press release • Corporate Law & Transactions from Stephan Strass, Markus Reinfeld, Alyssa Nimmervoll

BRANDL TALOS has advised Austrian techbio company Graph Therapeutics on an additional USD 5 million financing, led by Paris-based venture capital firm daphni with participation of the existing investors SquareOne Venture Capital, Merantix Capital and NAVEC Investment Management.

BRANDL TALOS advises shareholders of contextflow on the sale to 4DMedical

Press release • Corporate Law & Transactions from Roman Rericha, Markus Arzt, Adrian Zuschmann, Nina Atanasovska

BRANDL TALOS advises shareholders of contextflow on the sale to 4DMedical